Investor mix
11 investors on record; lead investors include IAG Capital Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 2 | 18% |
| Accelerator & incubator | 4 | 36% |
| Other / undisclosed | 2 | 18% |
Developing blood-cleansing device to remove pathogens from circulating blood
11 investors on record; lead investors include IAG Capital Partners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 27% |
| Private equity | 2 | 18% |
| Accelerator & incubator | 4 | 36% |
| Other / undisclosed | 2 | 18% |